Previous Close | 59.92 |
1-Year Change | -19.2% |
6-Months Change | -8.95% |
3-Months Change | -6.37% |
Moving Avg (50d) | 62.729 |
Moving Avg (200d) | 66.177 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 217.4M |
Beta (3-Years) | 0.64 |
Revenue Growth (ttm) | -0.3% |
Net Profit Margin (ttm) | 32.84% |
Return On Assets (ttm) | 12.88% |
EPS (ttm) | 4.64 |
PE Ratio (ttm) | 12.91 |
Dividend Yield | 1.97% |
Asset Description: | Utah Medical Products, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-01-29 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
61.118 | 62.916 | 64.114 | 65.912 | 68.908 | 71.904 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.